Last updated on January 2009

Donepezil Double Blind Trial for ECT Memory Disfunction

Brief description of study

This is a double blind randomized investigation of donepezil for patients suffering from schizophrenia, undergoing ECT. Patients will be randomized to receive either donezepil or plasebo, in order to gauge whether donezepil has a protective effect on memory disfunction, while patients are treated with ECT. Several parameters will be invistigated at baseline: general psychopathological measures, memory function scales, side effects scales. The same measurements will be taken throughout the trial and one month after ending the ECT.

Clinical Study Identifier: NCT00465283

Contact Investigators or Research Sites near you

Start Over

Tali Nachshoni, MD

Beer Yaakov MHC
Beer Yaacov, Israel
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.